Higgs algebraic symmetry of screened system in a spherical geometry

The orbits and the dynamical symmetries for the screened Coulomb potentials and isotropic harmonic oscillators have been studied by Wu and Zeng [Z. B. Wu and J. Y. Zeng, Phys. Rev. A 62,032509 (2000)]. We find the similar properties in the responding systems in a spherical space, whose dynamical symmetries are described by Higgs Algebra. There exists a conserved aphelion and perihelion vector, which, together with angular momentum, constitute the generators of the geometrical symmetry group at the aphelia and perihelia points $(\dot{r}=0)$.Comment: 8 pages, 1 fi

Neonatal screening for cystic fibrosis in São Paulo State, Brazil : a pilot study

Cystic fibrosis is one of the most common autosomal recessive hereditary diseases in the Caucasian population, with an incidence of 1:2000 to 1:3500 liveborns. More than 1000 mutations have been described with the most common being F508del. It has a prevalence of 23-55% within the Brazilian population. The lack of population-based studies evaluating the incidence of cystic fibrosis in São Paulo State, Brazil, and an analysis concerning the costs of implantation of a screening program motivated the present study. A total of 60,000 dried blood samples from Guthrie cards obtained from April 2005 to January 2006 for neonatal screening at 4 reference centers in São Paulo State were analyzed. The immunoreactive trypsinogen (IRT)/IRT protocol was used with the cut-off value being 70 ng/mL. A total of 532 children (0.9%) showed IRT >70 ng/mL and a 2nd sample was collected from 418 (80.3%) of these patients. Four affected children were detected at two centers, corresponding to an incidence of 1:8403. The average age at diagnosis was 69 days, and 3 of the children already showed severe symptoms of the disease. The rate of false-positive results was 95.2% and the positive predictive value for the test was 8%. The cost of detecting an affected subject was approximately US$8,000.00 when this cystic fibrosis program was added to an existing neonatal screening program. The present study clearly shows the difficulties involved in cystic fibrosis screening using the IRT/IRT protocol, particularly in a population with no long-term tradition of neonatal screening421

RICORS2040 : The need for collaborative research in chronic kidney disease

Chronic kidney disease (CKD) is a silent and poorly known killer. The current concept of CKD is relatively young and uptake by the public, physicians and health authorities is not widespread. Physicians still confuse CKD with chronic kidney insufficiency or failure. For the wider public and health authorities, CKD evokes kidney replacement therapy (KRT). In Spain, the prevalence of KRT is 0.13%. Thus health authorities may consider CKD a non-issue: very few persons eventually need KRT and, for those in whom kidneys fail, the problem is 'solved' by dialysis or kidney transplantation. However, KRT is the tip of the iceberg in the burden of CKD. The main burden of CKD is accelerated ageing and premature death. The cut-off points for kidney function and kidney damage indexes that define CKD also mark an increased risk for all-cause premature death. CKD is the most prevalent risk factor for lethal coronavirus disease 2019 (COVID-19) and the factor that most increases the risk of death in COVID-19, after old age. Men and women undergoing KRT still have an annual mortality that is 10- to 100-fold higher than similar-age peers, and life expectancy is shortened by ~40 years for young persons on dialysis and by 15 years for young persons with a functioning kidney graft. CKD is expected to become the fifth greatest global cause of death by 2040 and the second greatest cause of death in Spain before the end of the century, a time when one in four Spaniards will have CKD. However, by 2022, CKD will become the only top-15 global predicted cause of death that is not supported by a dedicated well-funded Centres for Biomedical Research (CIBER) network structure in Spain. Realizing the underestimation of the CKD burden of disease by health authorities, the Decade of the Kidney initiative for 2020-2030 was launched by the American Association of Kidney Patients and the European Kidney Health Alliance. Leading Spanish kidney researchers grouped in the kidney collaborative research network Red de Investigación Renal have now applied for the Redes de Investigación Cooperativa Orientadas a Resultados en Salud (RICORS) call for collaborative research in Spain with the support of the Spanish Society of Nephrology, Federación Nacional de Asociaciones para la Lucha Contra las Enfermedades del Riñón and ONT: RICORS2040 aims to prevent the dire predictions for the global 2040 burden of CKD from becoming true

Long-range Angular Correlations On The Near And Away Side In P-pb Collisions At √snn=5.02 Tev

7191/Mar294

Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries

Background Healthcare cannot achieve net-zero carbon without addressing operating theatres. The aim of this study was to prioritize feasible interventions to reduce the environmental impact of operating theatres. Methods This study adopted a four-phase Delphi consensus co-prioritization methodology. In phase 1, a systematic review of published interventions and global consultation of perioperative healthcare professionals were used to longlist interventions. In phase 2, iterative thematic analysis consolidated comparable interventions into a shortlist. In phase 3, the shortlist was co-prioritized based on patient and clinician views on acceptability, feasibility, and safety. In phase 4, ranked lists of interventions were presented by their relevance to high-income countries and low–middle-income countries. Results In phase 1, 43 interventions were identified, which had low uptake in practice according to 3042 professionals globally. In phase 2, a shortlist of 15 intervention domains was generated. In phase 3, interventions were deemed acceptable for more than 90 per cent of patients except for reducing general anaesthesia (84 per cent) and re-sterilization of ‘single-use’ consumables (86 per cent). In phase 4, the top three shortlisted interventions for high-income countries were: introducing recycling; reducing use of anaesthetic gases; and appropriate clinical waste processing. In phase 4, the top three shortlisted interventions for low–middle-income countries were: introducing reusable surgical devices; reducing use of consumables; and reducing the use of general anaesthesia. Conclusion This is a step toward environmentally sustainable operating environments with actionable interventions applicable to both high– and low–middle–income countries

Subclinical Regional Left Ventricular Dysfunction In Obese Patients With And Without Hypertension Or Hypertrophy

We investigated the impact of obesity on the abnormalities of systolic and diastolic regional left ventricular (LV) function in patients with or without hypertension or hypertrophy, and without heart failure. We studied 120 individuals divided into 6 groups of 20 patients (42 6 years, 60 females) using standard and pulsed-wave tissue Doppler imaging (TDI) echocardiography, and heterogeneity index (HI): nonobese (I: no hypertension, no hypertrophy, control group; II: hypertension, no hypertrophy; III: hypertension and hypertrophy) and obese (IV: no hypertension, no hypertrophy; V: hypertension, no hypertrophy; VI: hypertension and hypertrophy). The criterion for obesity was BMI 30kg/m -2, for hypertension was blood pressure 140/90mmHg, for hypertrophy in nonobese was LV mass/body surface area (BSA) 134g/m -2 (men) and 110mg/m -2 (women), and in obese was LV mass/height (2.7) 50 (men) and 40 (women). Obese groups had normal LV ejection fraction compared with nonobese groups, but decreased longitudinal and radial systolic myocardial peak velocities (S′), and early diastolic myocardial peak velocity (E′). Also, a great variability of E′ and late diastolic myocardial peak velocity (A′) from the longitudinal basal region was observed in obese groups (E′basal nonobese: 11 7 vs. obese 19 11, P 0.001, A′basal nonobese: 7 4 vs. obese 11 7, P 0.001). Our findings were more evident when comparing groups IV with V and VI, with the latter having concentric hypertrophy and obvious segmental systolic and diastolic dysfunctions. Subclinical myocardial alterations and increased variability of the velocities were observed in obese groups, especially with hypertension and hypertrophy, reflecting impaired regional LV relaxation, segmental atrial, and systolic dysfunctions. © 2011 The Obesity Society.19612961303Casale, P.N., Devereux, R.B., Milner, M., Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men (1986) Annals of Internal Medicine, 105 (2), pp. 173-178Manson, J.E., Willett, W.C., Stampfer, M.J., Body weight and mortality among women (1995) N Engl J Med, 333, pp. 677-685Must, A., Spadano, J., Coakley, E.H., Field, A.E., Colditz, G., Dietz, W.H., The disease burden associated with overweight and obesity (1999) Journal of the American Medical Association, 282 (16), pp. 1523-1529. , DOI 10.1001/jama.282.16.1523Hubert, H.B., Feinleib, M., McNamara, P.M., Castelli, W.P., Obesity as an independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the Framingham Heart Study (1983) Circulation, 67 (5), pp. 968-977Kenchaiah, S., Evans, J.C., Levy, D., Wilson, P.W.F., Benjamin, E.J., Larson, M.G., Kannel, W.B., Vasan, R.S., Obesity and the risk of heart failure (2002) New England Journal of Medicine, 347 (5), pp. 305-313. , DOI 10.1056/NEJMoa020245Murphy, N.F., MacIntyre, K., Stewart, S., Hart, C.L., Hole, D., McMurray, J.J.V., Long-term cardiovascular consequences of obesity: 20-Year follow-up of more than 15 000 middle-aged men and women (the Renfrew-Paisley study) (2006) European Heart Journal, 27 (1), pp. 96-106. , DOI 10.1093/eurheartj/ehi506Calle, E.E., Thun, M.J., Petrelli, J.M., Rodriguez, C., Heath Jr., C.W., Body-mass index and mortality in a prospective cohort of U.S. adults (1999) New England Journal of Medicine, 341 (15), pp. 1097-1105. , DOI 10.1056/NEJM199910073411501Levy, D., Garrison, R.J., Savage, D.D., Kannel, W.B., Castelli, W.P., Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study (1990) New England Journal of Medicine, 322 (22), pp. 1561-1566Devereux, R.B., Alonso, D.R., Lutas, E.M., Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings (1986) American Journal of Cardiology, 57 (6), pp. 450-458. , DOI 10.1016/0002-9149(86)90771-XMacMahon, S.W., Wilcken, D.E.L., Macdonald, G.J., The effect of weight reduction on left ventricular mass. A randomized controlled trial in young, overweight hypertensive patients (1986) New England Journal of Medicine, 314 (6), pp. 334-339Messerli, F.H., Christie, B., DeCarvalho, J.G.R., Obesity and essential hypertension. Hemodynamics, intravascular volume, sodium excretion, and plasma renin activity (1981) Archives of Internal Medicine, 141 (1), pp. 81-85. , DOI 10.1001/archinte.141.1.81Barouch, L.A., Berkowitz, D.E., Harrison, R.W., O'Donnell, C.P., Hare, J.M., Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice (2003) Circulation, 108 (6), pp. 754-759. , DOI 10.1161/01.CIR.0000083716.82622.FDAlpert, M.A., Obesity cardiomyopathy: Pathophysiology and evolution of the clinical syndrome (2001) American Journal of the Medical Sciences, 321 (4), pp. 225-236Redfield, M.M., Jacobsen, S.J., Burnett Jr., J.C., Mahoney, D.W., Bailey, K.R., Rodeheffer, R.J., Burden of systolic and diastolic ventricular dysfunction in the community: Appreciating the scope of the heart failure epidemic (2003) Journal of the American Medical Association, 289 (2), pp. 194-202. , DOI 10.1001/jama.289.2.194Levy, D., Larson, M.G., Vasan, R.S., Kannel, W.B., Ho, K.K.L., The progression from hypertension to congestive heart failure (1996) Journal of the American Medical Association, 275 (20), pp. 1557-1562. , DOI 10.1001/jama.275.20.1557Peterson, L.R., Waggoner, A.D., Schechtman, K.B., Meyer, T., Gropler, R.J., Barzilai, B., Davila-Roman, V.G., Alterations in left ventricular structure and function in young healthy obese women: Assessment by echocardiography and tissue Doppler imaging (2004) Journal of the American College of Cardiology, 43 (8), pp. 1399-1404. , DOI 10.1016/j.jacc.2003.10.062, PII S0735109704001974The 7th report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure -JNC VII (2003) JAMA, 289, pp. 1560-1572De Simone, G., Daniels, S.R., Devereux, R.B., Left ventricular mass and body size in normotensive children and adults: Assessment of allometric relations and impact of overweight (1992) J Am Coll Cardiol, 20, pp. 1251-1260Lang, R.M., Bierig, M., Devereux, R.B., Flachskampf, F.A., Foster, E., Pellikka, P.A., Picard, M.H., Stewart, W.J., Recommendations for chamber quantification: A report from the American Society of Echocardiography's guidelines and standards committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology (2005) Journal of the American Society of Echocardiography, 18 (12), pp. 1440-1463. , DOI 10.1016/j.echo.2005.10.005, PII S0894731705009831Quiñones, M.A., Otto, C.M., Stoddard, M., Waggoner, A., Zoghbi, W.A., Recommendations for quantification of Doppler echocardiography: A report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography (2002) J Am Soc Echocardiogr, 15, pp. 167-184. , Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of EchocardiographyNagueh, S.F., Appleton, C.P., Gillebert, T.C., Recommendations for the evaluation of left ventricular diastolic function by echocardiography (2009) J Am Soc Echocardiogr, 22, pp. 107-133Cardim, N., Oliveira, A.G., Longo, S., Ferreira, T., Pereira, A., Reis, R.P., Correia, J.M., Doppler tissue imaging: Regional myocardial function in hypertrophic cardiomyopathy and in athlete's heart (2003) Journal of the American Society of Echocardiography, 16 (3), pp. 223-232. , DOI 10.1067/mje.2003.13Krishnan, R., Becker, R.J., Beighley, L.M., Lopez-Candales, A., Impact of body mass index on markers of left ventricular thickness and mass calculation: Results of a pilot analysis (2005) Echocardiography, 22 (3), pp. 203-210. , DOI 10.1111/j.0742-2822.2005.03138.xLauer, M.S., Anderson, K.M., Levy, D., Separate and joint influences of obesity and mild hypertension on left ventricular mass and geometry: The Framingham Heart Study (1992) J Am Coll Cardiol, 19, pp. 130-134Willens, H.J., Chakko, S.C., Lowery, M.H., Byers, P., Labrador, E., Gallagher, A., Castrillon, J.C., Myerburg, R.J., Tissue Doppler imaging of the right and left ventricle in severe obesity (body mass index >35 kg/m 2) (2004) American Journal of Cardiology, 94 (8), pp. 1087-1090. , DOI 10.1016/j.amjcard.2004.06.076, PII S0002914904010847Wong, C.Y., O'Moore-Sullivan, T., Leano, R., Byrne, N., Beller, E., Marwick, T.H., Alterations of left ventricular myocardial characteristics associated with obesity (2004) Circulation, 110 (19), pp. 3081-3087. , DOI 10.1161/01.CIR.0000147184.13872.0FRen, J., Sowers, J.R., Walsh, M.F., Brown, R.A., Reduced contractile response to insulin and IGF-I in ventricular myocytes from genetically obese Zucker rats (2000) Am J Physiol Heart Circ Physiol, 279, pp. H1708-H1714Amad, K.H., Brennan, J.C., Alexander, J.K., The cardiac pathology of chronic exogenous obesity (1965) Circulation, 32, pp. 740-745Alpert, M.A., Terry, B.E., Mulekar, M., Cohen, M.V., Massey, C.V., Fan, T.M., Panayiotou, H., Mukerji, V., Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss (1997) American Journal of Cardiology, 80 (6), pp. 736-740. , DOI 10.1016/S0002-9149(97)00505-5, PII S0002914997005055Rodriguez, L., Garcia, M., Ares, M., Griffin, B.P., Nakatani, S., Thomas, J.D., Assessment of mitral annular dynamics during diastole by Doppler tissue imaging: Comparison with mitral Doppler inflow in subjects without heart disease and in patients with left ventricular hypertrophy (1996) American Heart Journal, 131 (5), pp. 982-987. , DOI 10.1016/S0002-8703(96)90183-0Di Salvo, G., Pacileo, G., Del Giudice, E.M., Natale, F., Limongelli, G., Verrengia, M., Rea, A., Calabro, R., Abnormal myocardial deformation properties in obese, non-hypertensive children: An ambulatory blood pressure monitoring, standard echocardiographic, and strain rate imaging study (2006) European Heart Journal, 27 (22), pp. 2689-2695. , DOI 10.1093/eurheartj/ehl163Ballo, P., Motto, A., Mondillo, S., Faraguti, S.A., Impact of obesity on left ventricular mass and function in subjects with chronic volume overload (2007) Obesity, 15 (8), pp. 2019-2026Dasgupta, P., Ramhanmdany, E., Brigden, G., Improvement in left ventricular function after rapid weight loss in obesity (1992) Eur Heart J, 13, pp. 1060-1066Willens, H.J., Chakko, S.C., Byers, P., Chirinos, J.A., Labrador, E., Castrillon, J.C., Lowery, M.H., Effects of weight loss after gastric bypass on right and left ventricular function assessed by tissue doppler imaging (2005) American Journal of Cardiology, 95 (12), pp. 1521-1524. , DOI 10.1016/j.amjcard.2005.02.029, PII S000291490500490